Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage

Neurosurgery
V SeifertC Goetz

Abstract

Premature lysis of subarachnoid blood clots by thrombolytic substances such as urokinase and plasmin has been shown to be efficacious in preventing cerebral vasospasm in clinical and experimental investigations. Recently, tissue plasminogen activator (rtPA) derived from recombinant deoxyribonucleic (DNA) technology has been introduced as a new thrombolytic substance. With its high affinity for fibrin-bound plasminogen and low affinity for circulating plasminogen by which a clot-selective fibrinolysis can be achieved without the danger of inducing systemic fibrinogenolysis, rtPA might be the ideal substance for the postoperative lysis of cisternal blood accumulations after subarachnoid hemorrhage. The efficacy of rtPA in preventing delayed cerebral vasospasm after experimental subarachnoid hemorrhage using a single intracisternal bolus injection of this agent was investigated. With a single injection of 25 micrograms of rtPA into the cisterna magna 48 hours after the first and 6 hours after the second injection of blood in the two-hemorrhage model of cerebral vasospasm, angiographic spasm of the basilar artery was completely prevented in all animals so treated whereas in the control group severe vasospasm occurred. Autopsy studi...Continue Reading

Citations

Oct 3, 2008·Neurosurgical Review·Uzma Samadani, Veit Rohde
Dec 1, 1993·Journal of Neuroscience Methods·M KaoutzanisJ W Peterson
Sep 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·T A Kopitnik, D S Samson
Jul 6, 2014·Neurosurgery Clinics of North America·Christopher D Baggott, Beverley Aagaard-Kienitz
Apr 27, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tommaso ZoerleR Loch Macdonald
Jan 1, 1992·Progress in Cardiovascular Diseases·S R Levine, T G Brott
Jan 1, 1997·Critical Care Clinics·D Jichici, J I Frank
Jul 1, 1995·Journal of Neurosurgery·K KinugasaY Matsumoto
Sep 1, 1996·Stroke; a Journal of Cerebral Circulation·C J KimL M Johns
Apr 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·V RohdeW E Hassler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.